LDH-D Antibodies

Santa Cruz Biotechnology features a diverse variety of LDH-D monoclonal antibodies for research focused on understanding lactate dehydrogenase D (LDH-D) and its role in cellular metabolism. LDH-D Antibodies are validated for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Lactate dehydrogenase D is an essential enzyme involved in the conversion of lactate to pyruvate, playing a crucial role in the metabolic processes of cells, particularly during anaerobic respiration. LDH-D has been identified as a key factor in various physiological and pathological conditions, making it a significant target for research in cancer metabolism and tissue injury. Understanding the function and regulation of LDH-D can provide insights into metabolic disorders and potential therapeutic strategies. Research utilizing LDH-D monoclonal antibodies has revealed important mechanisms in cellular energy production and metabolism. Scientists have made significant discoveries about LDH-D's involvement in disease progression and treatment approaches. Investigating LDH-D expression patterns has led to better understanding of metabolic adaptations in different tissue types. Santa Cruz Biotechnology monoclonal antibodies for LDH-D research continue to support scientists in making important discoveries that advance our understanding of cellular metabolism and disease mechanisms.